New research on Sigma Healthcare highlights management’s conservative cost synergy target, as well as potential market share gains and operating leverage
A decline in Services revenue had led to another profit downgrade from Cochlear, but brokers look ahead to new product launches
Aurizon Holdings has won a long term copper haulage contract with BHP, but is it enough to stem the company’s tide of negative revisions?
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
Independent Investment Research updates developments in Australia’s listed investment trust and provides comparative data
Treasury Wine Estates has downgraded FY25 guidance and revealed the loss of a major distributor in California. With a new CEO arriving in October, the company has plenty of uncertainties to deal with for the year(s) ahead
How CommBank became the poster stock for tactical asset allocation in a world of rising geopolitical risks and weaponisation of capital flows and the US dollar
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
This week’s profit warning confirmed IDP Education truly is swimming against the global tide, but could the bottom be in sight for this once popular high flier?
A consensus-beating FY25 result from Fisher & Paykel Healthcare was undermined by disappointing FY26 guidance, with tariffs partly to blame